glp 1 injections scottsdale GLP-1 Medications for Effective Weight Loss in GLP-1 Boom Is Creating Winners

While 96% of employers cover GLP-1s for diabetes, 67% are expanding coverage to include weight management, raising concerns about long-term cost implications for 96% of employers

Liraglutide, a once daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)

The high heterogeneity of the results likely responds to different baseline A1c, variable rates of obesity, as well as different titration protocols to adjust insulin doses

Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, United Kingdom

Indian J Forensic Med Toxicol